Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
Ready to proceed? Start a request for Ivarmacitinib on our secure patient portal to submit your prescription, upload documents and track your approval status.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
China
Regulatory Approval:
Your Trustworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Ivarmacitinib is a once-daily tablet that calms an overactive immune system. It was developed in China by Jiangsu Hengrui Pharmaceuticals, where it is sold as 艾速达® and is also known by its research code SHR0302. It is used across several long-term inflammatory conditions of the joints, spine and skin.
China's National Medical Products Administration (NMPA) has approved it for adults with:
It is a prescription immunology medicine and should be started and monitored by a rheumatologist or dermatologist.
Many inflammatory signals pass their message into immune cells through enzymes called Janus kinases (JAKs). Ivarmacitinib is a highly selective blocker of JAK1, so it turns down several of these inflammatory signals at once. This reduces joint swelling and back pain in arthritis, itching and rash in eczema, and the immune attack on hair follicles in alopecia areata.
It is taken by mouth once a day. The tablets in China are 4 mg. In the trials:
The approved dose for each condition is set out in the Chinese prescribing information, and your specialist will decide the right dose for you.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Infections: because it damps down the immune system, infections can be more likely. In the rheumatoid arthritis trial, infection-related side effects were slightly more common than with placebo. In the eczema trial, upper respiratory tract infections affected about 11% in every group, shingles (herpes zoster) occurred in 2.7% on 4 mg and 0.9% on 8 mg (none on placebo), and serious infections in 1.8% on 4 mg. Report fever, cough, painful blisters or any infection that will not settle.
Safety in pregnancy and breastfeeding has not been established. Discuss contraception with your doctor before starting.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
The tablets can be imported only in the patient's name, by the patient or a government hospital, in line with India's import regulations for unapproved medicines. You will need:
Once we have received and checked a valid prescription and, where needed, an import permit.
No. It is approved only in China. It has no CDSCO approval, it is not sold in Indian pharmacies, and the US FDA and European Medicines Agency have not approved it either.
Patients can still get it legally through the Named Patient Program (NPP), which allows a medicine not registered in India to be imported for one specific patient on a prescription. You can also read about Litfulo for alopecia areata and Orencia for rheumatoid arthritis on our site.
It can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.
NamedPatientProgram.com (NPP) sources this medicine through the manufacturer's authorised supply channels in China and arranges supply to patients, doctors, and hospitals under applicable legal provisions. The 4 mg tablets stay in their sealed original packs, stored as directed on the pack, and travel under temperature-controlled shipping. As it is a once-daily, long-term treatment, we can plan repeat supplies so there is no break between packs. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.
For the current cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.
Patients across India can access this medicine through regulated import pathways, with delivery arranged to the patient or the treating clinic on a valid specialist's prescription.
Rheumatology and dermatology centres here treat patients from across North India, and our New Delhi dispatch point keeps delivery quick.
Specialists in Mumbai can share the prescription and reports with us to begin the import in the patient's name.
Patients in Bangalore receive a clear written quote first, then delivery to home or the clinic.
A major referral centre for arthritis and skin disease in South India, familiar with imported medicines for named patients.
We set up regular resupply for patients in Hyderabad so the daily dose is never missed.
Patients in Kolkata and the eastern states can use the same documented import route, with updates at each step.
The tablets can be delivered to Pune once the prescription and permit are in order.
Doctors in Ahmedabad can check availability with us before finalising the treatment plan.
Patients followed up at hospitals in Vellore can have supplies sent to the treating team or to their home.
Serves patients from Punjab, Haryana and Himachal Pradesh, with delivery to home or the treating clinic.
We coordinate delivery for patients treated at rheumatology and skin clinics across Uttar Pradesh.
Patients across Kerala can receive each supply in Kochi and nearby cities.
Access can also be coordinated for patients in other Indian cities, subject to a valid prescription and regulatory requirements.
Written By
Nitin GoswamiDeputy Manager – Content & Social Media, Ikris Pharma Network
Sources: NMPA • CDSCO
Last Updated: 19 October 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
